Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15050515
Abstract: Imiquimod (IMQ) is a potent immune response modifier with antiviral and antitumor properties. IMQ’s low aqueous solubility and unsatisfactory cutaneous permeability limit its formulation into effective dosage forms. This work aimed to develop IMQ-loaded microemulsions… read more here.
Keywords: cutaneous imiquimod; phospholipid based; imq; microemulsions cutaneous ... See more keywords